Skip to main content
SpringerLink
Log in

An Example of Model Structure Differences Using Sensitivity Analyses in Physiologically Based Pharmacokinetic Models of Trichloroethylene in Humans

  • Original Article
  • Published:
Bulletin of Mathematical Biology Aims and scope Submit manuscript

Abstract

Trichloroethylene (TCE) is an industrial chemical and an environmental contaminant. TCE and its metabolites may be carcinogenic and affect human health. Physiologically based pharmacokinetic (PBPK) models that differ in compartmentalization are developed for TCE metabolism in humans, and the focus of this investigation is to evaluate alternative models. The two models formulated differ in the compartmentalization of metabolites; more specifically, one model has compartments for all chemicals and the other model has only a generalized body compartment for each the metabolites and contains multiple compartments for the parent, TCE. The models are compared through sensitivity analyses in order to selectively discriminate with regards to model structure. Sensitivities to a parameter of cardiac output (Q cc ) are calculated, and the more compartmentalized model predictions for excretion show lower sensitivity to changes in this parameter. Values of Q cc used in the sensitivity analyses are specifically chosen to be applicable to adults of ages into the low 60s. Since information about cardiac output across a population is not often incorporated into a PBPK model, the more compartmentalized (“full”) model is probably a more appropriate mathematical description of TCE metabolism, but further study may be necessary to decide which model is a more reasonable option if distributional information about Q cc is used. The study is intended to illustrate how sensitivity analysis can be used in order to make appropriate decisions about model development when considering physiological parameters than vary across the population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abbas, R., Fisher, J.W., 1997. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. Toxicol. Appl. Pharmacol. 147, 15–30.

    Article  Google Scholar 

  • Allen, B.C., Fisher, J.W., 1993. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Anal. 13(1), 71–86.

    Article  Google Scholar 

  • Banks, H.T., Ma, Y., Potter, L.K., 2005. A simulation-based comparison between parametric and nonparametric estimation methods in PBPK models. J. Inverse Ill-Posed Probl. 13(1), 1–26.

    Article  MATH  MathSciNet  Google Scholar 

  • Beck, J., Arnold, K., 1977. Parameter Estimation in Engineering and Science. Wiley Series in Probability and Mathematical Statistics. Wiley, New York. pp. 17–19.

    Google Scholar 

  • Boyes, W.K., Bushnell, P.J., Crofton, K.M., Evans, M., Simmons, J.E., 2000. Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario. Environ. Heal. Perspect. Suppl. 108(Suppl. 2), 317–322.

    Google Scholar 

  • Brandfonbrenner, M., Landowne, M., Shock, N.W., 1955. Changes in cardiac output with age. Circulation 12, 557–566.

    Google Scholar 

  • Brown, R.P., Delp, M.D., Lindstedt, S.L., Rhomberg, L.R., Beliles, R.P., 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Heal. 13(4), 407–484.

    Google Scholar 

  • Brüning, T., Bolt, H.M., 2000. Renal toxicity and carcinogenicity of trichloroethylene: key results, mechanisms, and controversies. Critical Rev. Toxicol. 30(3), 253–285.

    Article  Google Scholar 

  • Caldwell, J.C., Keshava, N., 2006. Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis. Environ. Heal. Perspect. 114(9), 1457–1463.

    Google Scholar 

  • Chiu, W.A., Caldwell, J.C., Keshava, N., Scott, C.S., 2006a. Key scientific issues in the health risk assessment of trichloroethylene. Environ. Heal. Perspect. 114(9), 1445–1449.

    Google Scholar 

  • Chiu, W.A., Okino, M.S., Lipscomb, J.C., Evans, M.V., 2006b. Issues in the pharmacokinetics of trichloroethylene and its metabolites. Environ. Heal. Perspect. 114(9), 1450–1456.

    Article  Google Scholar 

  • Clewell, H.J., Gentry, P.R., Covington, T.R., Gearhart, J.M., 2000. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ. Heal. Perspect. Suppl. 108(Suppl. 2), 283–305.

    Google Scholar 

  • Cole, W.J., Mitchell, R.G., Salamonsen, R.F., 1975. Isolation, characterization and quantitation of chloral hydrate as a transient metabolite of trichloroethylene in man using electron capture gas chromatography and mass fragmentography. J. Pharm. Pharmacol. 27, 167–171.

    Google Scholar 

  • El-Masri, H.A., Portier, C., 1998. Physiologically based pharmacokinetics model of primidone and its metabolites phenobarbital and phenylethylmalonamide in humans, rats, and mice. Drug Metab. Dispos. 26(6), 585–594.

    Google Scholar 

  • Fisher, J.W., 2000. Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites. Environ. Heal. Perspect. Suppl. 108(Suppl. 2), 265–273.

    Google Scholar 

  • Fisher, J.W., Mahle, D., Abbas, R., 1998. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. Toxicol. Appl. Pharmacol. 152, 339–359.

    Article  Google Scholar 

  • Greenberg, M.S., Burton, G.A. Jr., Fisher, J.W., 1999. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice. Toxicol. Appl. Pharmacol. 154, 264–278.

    Article  Google Scholar 

  • Lash, L.H., Fisher, J.W., Lipscomb, J.C., Parker, J.C., 2000a. Metabolism of trichloroethylene. Environ. Heal. Perspect. Suppl. 108(Suppl. 2), 177–200.

    Google Scholar 

  • Lash, L.H., Parker, J.C., Scott, C.S., 2000b. Models of action of trichloroethylene for kidney tumorigenesis. Environ. Heal. Perspect. Suppl. 108(Suppl. 2), 225–240.

    Google Scholar 

  • Löscher, W., Potschka, H., 2005. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Progr. Neurobiol. 76(1), 22–76.

    Article  Google Scholar 

  • Muller, G., Spassovski, M., Henschler, D., 1974. Metabolism of trichloroethylene in man. II. Pharmacokinetics of metabolites. Arch. Toxicol. 32, 283–295.

    Article  Google Scholar 

  • Muller, G., Spassovski, M., Henschler, D., 1975. Metabolism of trichloroethylene in man. III. Interaction of trichloroethylene and ethanol. Arch. Toxicol. 33, 173–189.

    Article  Google Scholar 

  • Okino, M.S., Chiu, W.A., Evans, M.V., Power, F.W., Lipscomb, J.C., Tornero-Velez, R., Dary, C.C., Blancato, J.N., Chen, C., Birnbaum, L.S., 2005. Suitability of using in vitro and computationally estimated parameters in simplified pharmacokinetic models. Drug Metab. Rev. 37(Suppl. 2), 162.

    Google Scholar 

  • Pastino, G.M., Yap, W.Y., Carroquino, M., 2000. Human variability and susceptibility to trichloroethylene. Environ. Heal. Perspect. Suppl. 108(Suppl. 2), 201–214.

    Google Scholar 

  • Price, P.S., Conolly, R.B., Chaisson, C.F., Gross, E.A., Young, J.S., Mathis, E.T., Tedder, D.R., 2003. Modeling interindividual variation in physiological factors used in PBPK models of humans. Critical Rev. Toxicol. 33(5), 469–503.

    Article  Google Scholar 

  • Sato, A., Nakajima, T., Fujiwara, Y., Murayama, N., 1977. A pharmacokinetic model to study the excretion of trichloroethylene and its metabolites after an inhalation exposure. Br. J. Ind. Med. 34, 56–63.

    Google Scholar 

  • Simmons, J.E., Boyes, W.K., Bushnell, P.J., Raymer, J.H., Limsakun, T., McDonald, A., Sey, Y.M., Evans, M.V., 2002. A physiologically based pharmacokinetic model for trichloroethylene in the male long-evans rat. Toxicol. Sci. 69, 3–15.

    Article  Google Scholar 

  • Toxicology Excellence for Risk Assessment (TERA), 2004. Development of a physiologically-based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Prepared for the United States Air Force by USAF-EPA TCE PBPK workgroup, 14 October 14 2004. (http://www.tera.org/vera/TCE/TCE%20PBPK%20harmonization%20document.pdf)

  • Wartenberg, D., Reyner, D., Scott, C.S., 2000. Trichloroethylene and cancer: epidemiologic evidence. Environ. Heal. Perspect. Suppl. 108(Suppl. 2), 161–176.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of North Carolina, Curriculum in Toxicology, Chapel Hill, NC, USA

    Karen A. Yokley

  2. U.S. Environmental Protection Agency, ORD/NHEERL/ETD/PKB, RTP, Mail Code: B143-01, 109 Alexander Drive, Durham, NC, 27711, USA

    Marina V. Evans

Authors
  1. Karen A. Yokley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marina V. Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karen A. Yokley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yokley, K.A., Evans, M.V. An Example of Model Structure Differences Using Sensitivity Analyses in Physiologically Based Pharmacokinetic Models of Trichloroethylene in Humans. Bull. Math. Biol. 69, 2591–2625 (2007). https://doi.org/10.1007/s11538-007-9233-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11538-007-9233-x

Keywords

Search

Navigation